Innate Immunity in Hepatitis C Virus Infection

Cold Spring Harb Perspect Med. 2021 Feb 1;11(2):a036988. doi: 10.1101/cshperspect.a036988.

Abstract

Activation and viral control of the innate immune response are hallmarks of hepatitis C virus (HCV) infection and are major determinants of spontaneous clearance or progression to chronic infection and liver disease. In this review, we provide a contemporary overview of how HCV is sensed by the host cell to trigger innate immune activation and the mechanisms deployed by the virus to evade this response. Type I and III interferons (IFNs) are crucial mediators of antiviral innate immunity against HCV, and we specifically highlight the importance of IFN-λ host genetics for the outcome of HCV infection. Last, we focus on the proinflammatory responses elicited by HCV infection and describe our current understanding of how interleukin (IL)-1β signaling and cross talk between the IL-1β and IFN signaling pathways lead to sustained inflammation and increased risk of liver pathology.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Disease Progression*
  • Hepacivirus
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / immunology
  • Humans
  • Immunity, Innate
  • Interferon Lambda
  • Interferon Type I / immunology
  • Interferons / immunology
  • Liver / virology
  • Polymorphism, Single Nucleotide
  • Signal Transduction

Substances

  • Antiviral Agents
  • Interferon Type I
  • Interferons
  • Interferon Lambda